
COVID-19 Miniseries Episode 36: A Comprehensive Update on COVID-19
About this episode
This episode was recorded on June 5, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Raymund R. Razonable, M.D. (@RazonableMD)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
Up to about 50% of people infected with SARS-CoV-2 are asymptomatic spreaders. About 80% of those who are symptomatic, developing COVID-19, have mild disease displaying dry cough, fever, and fatigue. The resulting 20% of symptomatic patients accounts for those who develop progressive respiratory distress and sometimes multi-organ failure, among other complications. We’re learning more about anosmia, cardiac injury, and “COVID-toes.” What’s known about COVID-19 and SARS-CoV-2 continues to evolve. Dr. Raymund Razonable walks through a recently published update on the management of COVID-19.
Time Stamps: 1:18 - New signs and symptoms of COVID-19. 3:30 - Testing characteristics (sensitivity, specificity, and indications) of the molecular and serologic testing for SARS-CoV-2 6:22 - Risk factors and the prediction of disease progression for patients hospitalized with COVID-19 9:28 - Hyper-inflammatory syndrome and progression to multi-system organ failure syndrome 10:45 - Multisystem inflammatory syndrome in children (MIS-C) 11:22 - Cardiac complications - 3 factors 12:50 - Diagnosis and treatment of co-infection in hospitalized patients (COVID-19 and flu, COVID-19 and pneumonia) 16:31 - Evidence-based treatment based on the 3 phases of COVID-19 viremic phase, pneumonic phase, hyperinflammation phase 18:06 - Remdesivir update 21:00 - Hydroxychloroquine update 23:25 - Favipiravir and lopinavir-ritonavir update 23:53 - Treatment of the hyperinflammatory phase (sarilumab, tocilizumab, lenzilumab, anakinra,) 27:13 - Convalescent plasma 28:04 - Discharge and social determinants of health 33:40 - Telehealth and remote monitoring 35:40 - Health disparities and telehealth 37:47 - What’s the next development Infectious Disease specialists are looking for in relation to the COVID-19 pandemic?
See the article here: A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease-19 in the Hospital Setting https://doi.org/10.1016/j.mayocp.2020.05.010
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Get every episode summarized
Each time Mayo Clinic Talks publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Mayo Clinic Talks

Advancements in the Diagnosis and Treatment of Parkinson’s Disease
Mayo Clinic Talks

Parkinson’s Disease in Children and Young Adults
Mayo Clinic Talks

Mayo Clinic Proceedings: Diabetes and Novel Therapies for Diabetes
Mayo Clinic Talks

Mayo Clinic Proceedings: Healthy Aging
Mayo Clinic Talks